ArticleFrontiers in epidemiology2026
Malaria antibody responses augment surveillance in low-transmission settings in the Upper River Region, the Gambia.
Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In low-transmission malaria settings, routine surveillance often fails to detect asymptomatic infections in partially immune populations. P(Detect), defined as the proportion of infections captured by surveillance systems, serves as a proxy for both population immunity and surveillance completeness. We evaluated whether antibody responses to Methods: We analyzed data from 5,300 seropositive individuals across 32 villages in The Gambia following mass drug administration. Random forest classification models were used to predict low vs. high P(Detect) groups based on antibody responses to 19 Results: Models demonstrated strong discrimination between detectability groups, with PR AUCs of 0.92-0.93 in the <5% stratum and 0.89-0.90 in the <10% stratum using a reduced 8-antigen panel. PfSEA, PfMSP1-19, gSG6, and Etramp4.Ag2 were consistently important predictors, though rankings varied by transmission context. Individual antigen models outperformed combined immune score approaches. Discussion: Antibody profiles can identify populations where surveillance underestimates transmission due to immunity. Integrating serological data into surveillance systems may improve detection of hidden reservoirs and support more targeted malaria elimination strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.